Science News

... from universities, journals, and other research organizations

Possible Vaccine Target For Chlamydia Identified

Sep. 13, 2007 — Scientists at Children's Hospital of Pittsburgh of UPMC have identified a potential target for the development of a vaccine against Chlamydia trachomatis, the most prevalent sexually transmitted bacterial infection in the world.


Share This:

The researchers, led by Toni Darville, MD, chief of the Division of Pediatric Infectious Diseases at Children's, identified a plasmid-deficient strain of Chlamydia that, when investigated in an animal model of genital tract infection, failed to cause disease. Plasmids are small molecules of DNA.

"This finding represents a major step forward in our work to eventually develop a vaccine against chlamydial disease," said Dr. Darville, senior author of the study and also a professor of pediatrics and microbiology/immunology at the University of Pittsburgh School of Medicine. "If we can identify plasmid-deficient derivatives of the C. trachomatis strains that infect humans, they would have the potential to serve as a vaccine against this disease."

Dr. Darville is considered one of the world's foremost researchers of Chlamydia trachomatis, a bacterium which is the most frequently reported cause of sexually transmitted disease in the United States. Because symptoms are usually mild or absent, it can damage a woman's reproductive organs and cause irreversible damage, including infertility, before a woman ever recognizes a problem.

In this study, a plasmid-deficient strain derived from Chlamydia muridarum was introduced to mice. The mice became infected but did not develop the trademark signs of chlamydial disease, particularly damage to the oviduct, the tube that carries eggs from the ovaries, according to Catherine M. O'Connell, PhD, a researcher in Dr. Darville's laboratory and first author of the study.

"Not only did the mice not develop oviduct scarring after infection with the plasmid-deficient strain, we also found that the mice previously infected with these strains were protected against oviduct disease when later infected with fully virulent C. muridarum," Dr. O'Connell said.

Nearly 930,000 chlamydial infections were reported to the Centers for Disease Control and Prevention (CDC) in 2004. Under-reporting is substantial because most people with Chlamydia are not aware of their infections and do not seek testing. An estimated 2.8 million Americans are infected with Chlamydia each year, according to the CDC.

Results of their study are published in the Sept. 15 issue of the Journal of Immunology.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Children's Hospital of Pittsburgh, via EurekAlert!, a service of AAAS.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 137,313

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
  more breaking science news

Social Networks


Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

In Other News ...

Science Video News


Vaccine For Ear Infections

Infectious disease experts have completed clinical trials on a vaccine designed to eliminate chronic ear infections. The vaccine works on 7. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: